Repurposing Dihydropyridines for Treatment of Helicobacter pylori Infection

Antibiotic resistance is a major cause of the increasing failures in the current eradication therapies against Helicobacter pylori. In this scenario, repurposing drugs could be a valuable strategy to fast-track novel antimicrobial agents. In the present study, we analyzed the inhibitory capability o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pharmaceutics
Autors principals: González, Andrés, Casado, Javier, Chueca, Eduardo, Salillas, Sandra, Velázquez-Campoy, Adrián, Espinosa Angarica, Vladimir, Bénejat, Lucie, Guignard, Jérome, Giese, Alban, Sancho, Javier, Lehours, Philippe, Lanas, Ángel
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6969910/
https://ncbi.nlm.nih.gov/pubmed/31847484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics11120681
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars